ASN
PDLI

Advisory Services Network’s PDL BioPharma, Inc. PDLI Stock Holding History

Advisory Services Network’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-130
Closed – – 3959
2020
Q3 		$0 Buy
+130
New +$415 ﹤0.01% 3729
2014
Q2 		– Sell
-26,000
Closed -$216K – 271
2014
Q1 		$216K Hold
26,000
– – 0.11% 186
2013
Q4 		$219K Buy
+26,000
New +$219K 0.11% 168

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Advisory Services Network's PDLI Position: Q4 2020 in Review

Advisory Services Network sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 130 shares.

Advisory Services Network first reported a position in PDLI in Q4 2013 and held it in 3 quarters. The position peaked at $219K in Q4 2013. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Advisory Services Network reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 130 PDL BioPharma, Inc. shares in Q4 2020.
  • Advisory Services Network first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 3 quarters.
  • Advisory Services Network's PDL BioPharma, Inc. position peaked at $219K in Q4 2013.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.